Soda Health: Transforming Healthcare Benefits with $50M Infusion
Deal News | Dec 03, 2024 | General Catalyst Partners LLC

In a major strategic investment, General Catalyst is leading a $50 million Series B funding round for Soda Health, a company that seeks to modernize the payment and data systems of healthcare plans. The focus is on improving the efficiency and integration of supplemental benefits, such as those provided by Medicare Advantage plans, which currently account for $131 billion annually. Soda Health aims to enhance the utilization, reporting, and effectiveness of these benefits, which often operate in silos and lack strategic integration with care strategies. With utilization rates rising and capitation rates declining, MA plans are under pressure to manage costs and improve patient outcomes, making this investment timely. Soda Health's platform offers advanced fintech infrastructure and data collection capabilities, partnering with a robust retail network to influence patient engagement and healthcare outcomes positively. CEO Robby Knight and his co-founders bring significant expertise from their experiences at Walmart and elsewhere, underscoring the venture's potential to revolutionize the ecosystem.
Sectors
- Healthcare Technology
- Private Equity & Venture Capital
- Financial Services
Geography
- United States – Both General Catalyst and Soda Health are likely U.S.-based, and the discussion focuses on Medicare Advantage plans, primarily a U.S. healthcare program.
Industry
- Healthcare Technology – This industry is relevant due to Soda Health's focus on modernizing payment systems and enhancing data capabilities within healthcare plans.
- Private Equity & Venture Capital – General Catalyst's involvement in leading the $50 million Series B funding for Soda Health indicates significant private equity and venture capital activity.
- Financial Services – Soda Health's development of fintech infrastructure aimed at integrating supplemental benefits within healthcare plans links the article to financial services.
Financials
- $50,000,000 – The Series B funding amount invested by General Catalyst in Soda Health.
Participants
Name | Role | Type | Description |
---|---|---|---|
General Catalyst Partners LLC | Investor | Company | A private equity firm leading the $50 million Series B funding round for Soda Health. |
Soda Health | Target Company | Company | A company focused on modernizing payment systems within healthcare plans, recipient of General Catalyst's investment. |
Robby Knight | CEO | People | CEO of Soda Health, with expertise from serving as Head of Consumer Health Innovation at Walmart. |
Daryl Risinger | Co-Founder | People | Co-Founder of Soda Health with expertise in payment systems and retail integration. |
Chris Brown | Co-Founder | People | Co-Founder of Soda Health contributing to company growth and strategy. |
Jared Dauman | Co-Founder | People | Co-Founder of Soda Health, involved in expanding and advancing technological solutions in healthcare. |